The 45 DLBCL tumors with any frequency of FOXP1 and FOXP2 co-expression exhibited significantly inferior OS (P = 0.0251) and a trend towards inferior PFS (P = 0.0759) (Figure 4E–4F). This evidence concerns the gene FOXP1 and diffuse large B-cell lymphoma.